Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SymBio Pharma, Jul-Sep (3Q) Net Income Loss Narrows
Summary of Consolidated Financial Statements for the First Nine Months of the Fiscal Year Ending December 31, 2025 [Japanese GAAP]
SymBio Pharma, First Half Net Income Loss Widens, Apr-Jun Net Income Loss Widens
Summary of Consolidated Financial Statements for the First Six Months of Fiscal Year Ending December 31, 2025 [Japanese GAAP]
SymBio Pharma, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision
Revision to Earnings Forecast for FY 2025
SymBio Pharma, Jan-Mar (1Q) Net Income Loss Widens
Summary of Consolidated Financial Statements for the First Three Months of Fiscal Year Ending December 31, 2025 [Japanese GAAP]
SymBio Pharma, The Current Fiscal Year's Net Income to Widen
Summary of Financial Statements for the Fiscal Year Ended December 31, 2024 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals Limited, January-September (Third Quarter Cumulative) Net Income Loss Widens, July-September Net Income Loss Widens
Summary of Consolidated Financial Statements for the First Nine Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]